Vapotherm Inc
NYSE:VAPO
Vapotherm Inc
Revenue
Vapotherm Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vapotherm Inc
NYSE:VAPO
|
Revenue
$68.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Vapotherm Inc
Revenue Breakdown
Breakdown by Geography
Vapotherm Inc
Total Revenue:
68.7m
USD
|
United States:
51m
USD
|
Non-Us:
17.6m
USD
|
Breakdown by Segments
Vapotherm Inc
Total Revenue:
68.7m
USD
|
Product Revenue:
60.5m
USD
|
Service, Other:
5.8m
USD
|
See Also
What is Vapotherm Inc's Revenue?
Revenue
68.7m
USD
Based on the financial report for Dec 31, 2023, Vapotherm Inc's Revenue amounts to 68.7m USD.
What is Vapotherm Inc's Revenue growth rate?
Revenue CAGR 5Y
10%
Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Vapotherm Inc have been -18% over the past three years , 10% over the past five years .